Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.36% | -616.13% | 100.36% | 7.32% | -1,587.34% |
| Total Depreciation and Amortization | 8.33% | -70.30% | -79.12% | -55.43% | -53.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.78% | 116.93% | -93.87% | 154.73% | 137.82% |
| Change in Net Operating Assets | -451.67% | 61.28% | -1,050.00% | -125.44% | 105.24% |
| Cash from Operations | -4.85% | 32.64% | 2.13% | -39.23% | 19.27% |
| Capital Expenditure | 40.31% | -137.27% | -7.86% | 22.22% | -73.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 169.75% | 94.65% | -6.14% | -15.93% | -85.79% |
| Cash from Investing | 518.64% | -0.19% | -8.62% | -15.17% | -94.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 91.94% | -- | 101.79% | 96.00% |
| Issuance of Common Stock | -80.00% | -26.67% | 14.29% | 100.00% | 66.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -71.43% | 97.25% | 118.97% | 105.09% | 102.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.64% | 1,228.00% | 4.14% | 13.30% | -451.23% |